2019 Wendy and Emery Reves International Breast Cancer Symposium

Thank you for your interest in the Wendy and Emery Reves International Breast Cancer Symposium on September 20-21, 2019 in the T. Boone Pickens Biomedical Auditorium (NG3.112). Registration has closed as we have reached capacity. All participants must be registered to attend.

 

Exhibitors/Vendors

Overview

The Reves Symposium is a premier event at UT Southwestern Simmons Cancer Center whose objectives are to review the most recent progress in breast cancer, clinical trials, and clinical care of patients with breast cancer. The Reves Symposium provides information on the most current laboratory-based translational discoveries, while also addressing the latest developments in treatment options for patients, and population sciences. World-renowned leaders in the field will share information on:

  • Drug Resistance
  • De-Escalation of Therapy
  • Latest Clinical Trials
  • New Standards of Care
  • Population Sciences
  • Translational & Basic Science

Target Audience

Attendees include laboratory-based translational scientists, physician-scientists, clinical trialists, breast cancer care providers and nursing professionals, laboratory-based postdoctoral and clinical fellows, graduate students, patient advocates, and interested individuals from industry, regulatory agencies, and North Texas communities and beyond.

View the Agenda

Keynote Speakers

Lisa Carey, M.D.
Lisa Carey, M.D.

University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center

Carlos Caldas, M.D.
Carlos Caldas, M.D.

University of Cambridge
Cancer Research UK Cambridge Institute

 

Meet the Presenters

Suzanne Conzen, M.D.
Suzanne Conzen, M.D.

UT Southwestern/Simmons Comprehensive Cancer Center

Armando Giuliano, M.D.

 

Armando Giuliano, M.D.

Cedars-Sinai Hospital 

Andrew Koff, Ph.D.

 

Andrew Koff, Ph.D.

Memorial Sloan Kettering Cancer Center

W. Lee Kraus, Ph.D.

 

W. Lee Kraus, Ph.D.

UT Southwestern/Simmons Comprehensive Cancer Center

Ciara Metcalfe, Ph.D.

 

Ciara Metcalfe, Ph.D.

Genentech

Debra L. Monticciolo, M.D.

 

Debra L. Monticciolo, M.D.

Baylor Scott & White Medical Center

Nicholas Navin, Ph.D.

 

Nicholas Navin, Ph.D.

UT MD Anderson Cancer Center

Robert M. Nishikawa, Ph.D.

 

Robert M. Nishikawa, Ph.D.

University of Pittsburgh

Funmi-Olopade, M.D.

 

Olufunmilayo (Funmi) Olopade, M.D.

 

University of Chicago
Kornella Polyak, M.D., Ph.D.
Kornelia Polyak, M.D., Ph.D.

Dana-Farber Cancer Institute/Harvard

Timothy Rebbeck, Ph.D.

 

Timothy R. Rebbeck, Ph.D.

Dana-Farber Cancer Institute/Harvard 

Hope S. Rugo, M.D.

 

Hope S. Rugo, M.D.

UCSF Helen Diller Family Comprehensive Cancer Center

Joseph A. Sparano, M.D.

 

Joseph A. Sparano, M.D.

Montefiore Medical Center

Charles Swanton, M.D., Ph.D.

 

Charles Swanton, M.D., Ph.D.

The Francis Crick Institute

Sara M. Tolaney, M.D., M.P.H.

 

Sara M. Tolaney, M.D., M.P.H.

Dana-Farber Cancer Institute/Harvard

Nicholas Turner, M.D., Ph.D.

 

Nicholas C. Turner, M.D., Ph.D. 

Royal Marsden Hospital, UK

Nikhil Wagle, M.D.

 

Nikhil Wagle, M.D.

Dana-Farber Cancer Institute/Harvard


Presenters’ Topics

  • Tumor Heterogeneity
  • Advances in Surgery
  • Metabolism
  • Drug Resistance
  • Cell Cycle and CDK4/6 Inhibitors
  • Population Science, Cancer Risk, and Health Disparities
  • De-escalation of Therapy
  • Breast Cancer Detection/Imaging
  • Steroid Nuclear Receptors – and more

 For more information, contact 214-648-9664 / [SCCCEvents@UTSouthwestern.edu].